FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307633878> ?p ?o ?g. }

• W4307633878 endingPage "1770" @default.
• W4307633878 startingPage "1770" @default.
• W4307633878 abstract "Cytokine patterns and immune activation in patients with Coronavirus 2019 (COVID-19) seem to resemble the case of rheumatoid arthritis (RA), psoriasis and inflammatory bowel disease (IBD). Biological drugs, such as anti-tumor necrosis factor α (TNFα) and interleukin (IL) inhibitors, appear to be protective against adverse outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). However, these treatments are associated with an increased risk of secondary infections. The aim of the study was to examine the association between the use of immunomodulatory drugs and the risk of SARS-CoV-2-associated positivity, hospitalization and death compared to other commonly prescribed treatment regimens among patients with immune-mediated inflammatory diseases.All patients with RA, Psoriasis and IBD were included in this observational analysis and treated with anti-TNFα, IL-inhibitors, Methotrexate (MTX) and Sulfasalazine drugs during the year 2020-2021. The population consisted of 932 patients and demographic, clinical and pharmacological data were analyzed.Although no significant differences were observed between patients treated with biological and synthetic drugs in terms of hospitalization and death, the multivariate logistic model showed that the type of drug influences the possibility of COVID-19 positivity.The results of this analysis support the use of biological drugs and justify further research investigating the association of these biological therapies with COVID-19 outcomes." @default.
• W4307633878 created "2022-11-04" @default.
• W4307633878 creator A5001339042 @default.
• W4307633878 creator A5007868953 @default.
• W4307633878 creator A5012758979 @default.
• W4307633878 creator A5041284036 @default.
• W4307633878 creator A5050036608 @default.
• W4307633878 creator A5085791954 @default.
• W4307633878 creator A5086975666 @default.
• W4307633878 creator A5089051238 @default.
• W4307633878 date "2022-10-27" @default.
• W4307633878 modified "2023-09-30" @default.
• W4307633878 title "Anti-TNFα Drugs and Interleukin Inhibitors: Epidemiological and Pharmacovigilance Investigation in COVID-19 Positive Patients" @default.
• W4307633878 cites W2006741811 @default.
• W4307633878 cites W2101951838 @default.
• W4307633878 cites W2567039436 @default.
• W4307633878 cites W2783494524 @default.
• W4307633878 cites W2883191655 @default.
• W4307633878 cites W2896285785 @default.
• W4307633878 cites W2924895007 @default.
• W4307633878 cites W2984486845 @default.
• W4307633878 cites W2992412856 @default.
• W4307633878 cites W3024016727 @default.
• W4307633878 cites W3024177957 @default.
• W4307633878 cites W3024541652 @default.
• W4307633878 cites W3036280377 @default.
• W4307633878 cites W3036377737 @default.
• W4307633878 cites W3041319886 @default.
• W4307633878 cites W3043794926 @default.
• W4307633878 cites W3047115247 @default.
• W4307633878 cites W3093149116 @default.
• W4307633878 cites W3108032435 @default.
• W4307633878 cites W3108737232 @default.
• W4307633878 cites W3127398218 @default.
• W4307633878 cites W3132820286 @default.
• W4307633878 cites W3134454558 @default.
• W4307633878 cites W3166712067 @default.
• W4307633878 cites W3214626226 @default.
• W4307633878 cites W3217622265 @default.
• W4307633878 cites W4200103876 @default.
• W4307633878 cites W4313347683 @default.
• W4307633878 doi "https://doi.org/10.3390/jpm12111770" @default.
• W4307633878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36579506" @default.
• W4307633878 hasPublicationYear "2022" @default.
• W4307633878 type Work @default.
• W4307633878 citedByCount "0" @default.
• W4307633878 crossrefType "journal-article" @default.
• W4307633878 hasAuthorship W4307633878A5001339042 @default.
• W4307633878 hasAuthorship W4307633878A5007868953 @default.
• W4307633878 hasAuthorship W4307633878A5012758979 @default.
• W4307633878 hasAuthorship W4307633878A5041284036 @default.
• W4307633878 hasAuthorship W4307633878A5050036608 @default.
• W4307633878 hasAuthorship W4307633878A5085791954 @default.
• W4307633878 hasAuthorship W4307633878A5086975666 @default.
• W4307633878 hasAuthorship W4307633878A5089051238 @default.
• W4307633878 hasBestOaLocation W43076338781 @default.
• W4307633878 hasConcept C126322002 @default.
• W4307633878 hasConcept C17991360 @default.
• W4307633878 hasConcept C197934379 @default.
• W4307633878 hasConcept C203014093 @default.
• W4307633878 hasConcept C2777178219 @default.
• W4307633878 hasConcept C2777575956 @default.
• W4307633878 hasConcept C2779134260 @default.
• W4307633878 hasConcept C2779383735 @default.
• W4307633878 hasConcept C2780479503 @default.
• W4307633878 hasConcept C2780564577 @default.
• W4307633878 hasConcept C2781059491 @default.
• W4307633878 hasConcept C2908647359 @default.
• W4307633878 hasConcept C57658597 @default.
• W4307633878 hasConcept C71924100 @default.
• W4307633878 hasConcept C99454951 @default.
• W4307633878 hasConceptScore W4307633878C126322002 @default.
• W4307633878 hasConceptScore W4307633878C17991360 @default.
• W4307633878 hasConceptScore W4307633878C197934379 @default.
• W4307633878 hasConceptScore W4307633878C203014093 @default.
• W4307633878 hasConceptScore W4307633878C2777178219 @default.
• W4307633878 hasConceptScore W4307633878C2777575956 @default.
• W4307633878 hasConceptScore W4307633878C2779134260 @default.
• W4307633878 hasConceptScore W4307633878C2779383735 @default.
• W4307633878 hasConceptScore W4307633878C2780479503 @default.
• W4307633878 hasConceptScore W4307633878C2780564577 @default.
• W4307633878 hasConceptScore W4307633878C2781059491 @default.
• W4307633878 hasConceptScore W4307633878C2908647359 @default.
• W4307633878 hasConceptScore W4307633878C57658597 @default.
• W4307633878 hasConceptScore W4307633878C71924100 @default.
• W4307633878 hasConceptScore W4307633878C99454951 @default.
• W4307633878 hasIssue "11" @default.
• W4307633878 hasLocation W43076338781 @default.
• W4307633878 hasLocation W43076338782 @default.
• W4307633878 hasLocation W43076338783 @default.
• W4307633878 hasLocation W43076338784 @default.
• W4307633878 hasOpenAccess W4307633878 @default.
• W4307633878 hasPrimaryLocation W43076338781 @default.
• W4307633878 hasRelatedWork W189077404 @default.
• W4307633878 hasRelatedWork W2051823061 @default.
• W4307633878 hasRelatedWork W2053109122 @default.
• W4307633878 hasRelatedWork W2262622611 @default.
• W4307633878 hasRelatedWork W2320562573 @default.

• next